Popular on EntSun
- Higginswerx and Mirrorize Unveil 'Mirror 9: The Hollowing' - 438
- Hyperlens Studios Announces Planned Merger with Arclight, Ant Hill Productions, and Lemazing - 412
- Disney Streamer Network Establishes Creator Code of Conduct - 358
- Commercial Manufacturing Validation Completed as November 10 FDA Milestone Approaches; Critical FDA Milestone Close: NRx Pharmaceuticals NAS DAQ: NRXP - 226
- Western Canadian Host James Cousineau Finishes 11th In Global "Top Host" Competition - 211
- Majo Aguilar inaugurates the Paseo de las Estrellas at Plaza Mexico with the unveiling of her Estrella Maya - 191
- Movie&Short Festival 2027: Submissions Open for Short Films and Visual Arts - 187
- Air Force Veteran Sean Douglas Delivers Powerful Suicide Prevention Presentations to Hundreds of Marines at Camp Pendleton - 180
- Highsfield Showcases Earth Zoom Generator for Cinematic AI Videos - 173
- OncoBeta Introduces Rhenium-SCT for Non-Melanoma Skin Cancer at Theageneio Cancer Hospital of Thessaloniki - 165
Similar on EntSun
- Massive Acquisition Into Defense With STS for Virtuix Holdings; $40 Million Revenue Business Will Accelerate Growth Transforming Market Position
- Commercial Sales for U.S.-Made, Preservative-Free Ketamine Amid Long-Runnin Shortage Following FDA Approval by NRx Pharmaceuticals, Inc
- Contracting Resources Group Receives 2026 HIRE Vets Platinum Medallion Award
- Commercial Sales Launch Following FDA Approval; National Sales Force Now in Action as January Shipments and Major Market Opportunity Take Shape
- Contracting Resources Group Named a 2027 Elev8 GovCon Honoree by OrangeSlices
- Qscription Technologies Welcomes Joanna Krause, MD, MRMD to Its Clinical Advisory Board
- New Omega-3 Fish Oil Under NIH Investigation: What Makes It Different From EPA and DHA?
- OncoBeta Introduces Rhenium-SCT for Non-Melanoma Skin Cancer at Theageneio Cancer Hospital of Thessaloniki
- New Patient Data Show REQORSA® Activating Cellular Repair Pathways as Roche Collaboration Advances Precision Lung Cancer Strategy for Genprex, Inc
- New TROP2 Research Breakthrough Strengthens REQORSA® Gene Therapy Story as Roche Collaboration Advances Precision Lung Cancer Treatment: Genprex, Inc
Nutraceuticals & Agriceuticals Technology Company, Inc. Files For Patent Protection For Latest Invention Persimonal™ Persimmon Leaf Exctract- Powder
EntSun News/10824010
TEMECULA, Calif. - EntSun -- Press Release
Company: NATCO, Inc.
Contact: Abdul Alkayali
Telephone: (949-554-8853)
Email: asalkayali@natcohealthyliving.com
Website: www.natcohealthyliving.com
Temecula, California – May 15, 2020 - Nutraceuticals & Agriceuticlas Technology Company, Inc. is proud to announce the filling for patent protection for its newest invention of Persimmon Leaf Extract. Persimonal™ is the creation of many years of research and development under the management of Botanist Mr. Wude Mao of Guilin China.
Persimonal™ (Botanical Diospyros kaki Thunb) purification and extraction is under patent pending technology and uniquely supplies special flavonoids (class of polyphenolic plant) containing Quercetin and Kaempferol. Persimonal™ is composed of 8 ~ 10% flavoniods calculated as the sum of Quercetin and Kaempferol. Quercetin has antioxidant and anti-inflammatory effects that help reduce inflammation, kill cancer cells, control blood sugar, and help prevent heart disease.
More on EntSun News
For centuries, Asians have enjoyed the medicinal benefits of persimmon leaves and over the years documented the well-known positive effects on hypertension, lowering blood pressure, lowering cholesterol, and known to have positive effect on eczema.
This is exciting news for Nutraceuticals & Agriceuticals Technology Company, Inc. Mr. Ahmad Alkayali who is the CEO stated: this is the longevity breakthrough supplement of the century. NATCO is planning to market this unique supplement worldwide. Mr. Alkayali has worked in this industry for over 30 years and was the first to introduce anti-aging supplements to the market more than a quarter of a century ago. NATCO, Inc. specializes in botanical extracts such as Monk Fruit Extract, Bitter Orange Extract, Rosemary Extract, Andrographis Paniculata Extract, and NHDC.
For more information and availability, please contact our sales team at
NATCO, Inc. (949) 554-8853 – Fax: (951) 600-8676
info@natcohealthyliving.com www.natcohealthyliving.com
Company: NATCO, Inc.
Contact: Abdul Alkayali
Telephone: (949-554-8853)
Email: asalkayali@natcohealthyliving.com
Website: www.natcohealthyliving.com
Temecula, California – May 15, 2020 - Nutraceuticals & Agriceuticlas Technology Company, Inc. is proud to announce the filling for patent protection for its newest invention of Persimmon Leaf Extract. Persimonal™ is the creation of many years of research and development under the management of Botanist Mr. Wude Mao of Guilin China.
Persimonal™ (Botanical Diospyros kaki Thunb) purification and extraction is under patent pending technology and uniquely supplies special flavonoids (class of polyphenolic plant) containing Quercetin and Kaempferol. Persimonal™ is composed of 8 ~ 10% flavoniods calculated as the sum of Quercetin and Kaempferol. Quercetin has antioxidant and anti-inflammatory effects that help reduce inflammation, kill cancer cells, control blood sugar, and help prevent heart disease.
More on EntSun News
- Entertainment Vet Latrina Blackberry Brings Upscale 40+ Experience "The Congo Den" to Spring, Texas
- Music For Good: Brooklyn's Legendary Gleason's Gym Transforms Into A Live Music Venue For One Night
- Massive Acquisition Into Defense With STS for Virtuix Holdings; $40 Million Revenue Business Will Accelerate Growth Transforming Market Position
- The Dining Room Sees Everything
- Orlando Real Estate Broker Bent Danholm Wins 2026 Goody Business Book Award for The Architecture of Demand
For centuries, Asians have enjoyed the medicinal benefits of persimmon leaves and over the years documented the well-known positive effects on hypertension, lowering blood pressure, lowering cholesterol, and known to have positive effect on eczema.
This is exciting news for Nutraceuticals & Agriceuticals Technology Company, Inc. Mr. Ahmad Alkayali who is the CEO stated: this is the longevity breakthrough supplement of the century. NATCO is planning to market this unique supplement worldwide. Mr. Alkayali has worked in this industry for over 30 years and was the first to introduce anti-aging supplements to the market more than a quarter of a century ago. NATCO, Inc. specializes in botanical extracts such as Monk Fruit Extract, Bitter Orange Extract, Rosemary Extract, Andrographis Paniculata Extract, and NHDC.
For more information and availability, please contact our sales team at
NATCO, Inc. (949) 554-8853 – Fax: (951) 600-8676
info@natcohealthyliving.com www.natcohealthyliving.com
Source: NATCO Inc
0 Comments
Latest on EntSun News
- Security Planning Tips For Your Holiday Event From Access Patrol Services
- Contracting Resources Group Receives 2026 HIRE Vets Platinum Medallion Award
- It's a Wonderful Life: Live in Door County Marks a Milestone for TAP
- Business News & Info Goes Inside Paragon FX Group's Hunt for Original Film Props
- Las Vegas Comedy Headliner Don Barnhart Returns to Pechanga Thanksgiving Weekend Nov. 27–28
- Kitchen Table Economics: An Invitation to Think Differently
- Who Won New York Fashion Week SS27? Tommy Hilfiger Led the Media as Tory Burch Won the Critics
- Win a $5,000 VIP Family Experience at the 100th Thanksgiving Day Parade in New York City
- CB Stuffer Announces Private Sale to Secure Future of Brand Growth
- Brother Marcus Celebrates 400th Episode of The Elements of Inspiration Podcast
- The Swarthy Channel Opens The Swarthy Studio for Creators Raising Capital in Entertainment
- Connecting is our passion. — From Power to Data, Taking Connectivity to the Next Generation
- Gayle Skidmore Partners with RM Records; New Single "Old Photographs," Recorded in Prague, Out November 13 via Virgin Music Group
- The Fifth Annual "Bamboo Lantern Festival" to Illuminate Tokyo Mizumachi and Sumida River Walk®
- MetroLagoons launches College Lagoon Pass for students
- Iglesia.com Positioned in Multimillion-Dollar Domain Market with $10 Million Asking Price
- TCA VG: 2025 Funding Climbs to $9M across 43 Companies; Cumulative Returns Reach 5.3 MOIC & 22% IRR
- Searching for the Next LBE Creator: CalArts Launches First-Ever D.R.E.A.M.S. Pitch Competition
- Integris Composites Joins International Sea Power Conference Aboard HMS Prince of Wales
- Commercial Sales Launch Following FDA Approval; National Sales Force Now in Action as January Shipments and Major Market Opportunity Take Shape

